These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32048313)

  • 1. Adaptive multiarm multistage clinical trials.
    Ghosh P; Liu L; Mehta C
    Stat Med; 2020 Apr; 39(8):1084-1102. PubMed ID: 32048313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.
    Choodari-Oskooei B; Blenkinsop A; Handley K; Pinkney T; Parmar MKB
    BMC Med Res Methodol; 2024 Jun; 24(1):124. PubMed ID: 38831421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes.
    Bratton DJ; Parmar MK; Phillips PP; Choodari-Oskooei B
    Trials; 2016 Jul; 17(1):309. PubMed ID: 27369182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding experimental treatment arms to multi-arm multi-stage platform trials in progress.
    Burnett T; König F; Jaki T
    Stat Med; 2024 Aug; 43(18):3447-3462. PubMed ID: 38852991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the MAMS framework with the combination method in multi-arm adaptive trials with binary outcomes.
    Abery JE; Todd S
    Stat Methods Med Res; 2019 Jun; 28(6):1716-1730. PubMed ID: 29734869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An order restricted multi-arm multi-stage clinical trial design.
    Serra A; Mozgunov P; Jaki T
    Stat Med; 2022 Apr; 41(9):1613-1626. PubMed ID: 35048391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and monitoring of multi-arm multi-stage clinical trials.
    Ghosh P; Liu L; Senchaudhuri P; Gao P; Mehta C
    Biometrics; 2017 Dec; 73(4):1289-1299. PubMed ID: 28346823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis.
    Li V; Leurent B; Barkhof F; Braisher M; Cafferty F; Ciccarelli O; Eshaghi A; Gray E; Nicholas JM; Parmar M; Peryer G; Robertson J; Stallard N; Wason J; Chataway J
    Neurology; 2022 May; 98(18):754-764. PubMed ID: 35321926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group sequential multi-arm multi-stage trial design with treatment selection.
    Wu J; Li Y; Zhu L
    Stat Med; 2023 May; 42(10):1480-1491. PubMed ID: 36808736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding new experimental arms to randomised clinical trials: Impact on error rates.
    Choodari-Oskooei B; Bratton DJ; Gannon MR; Meade AM; Sydes MR; Parmar MK
    Clin Trials; 2020 Jun; 17(3):273-284. PubMed ID: 32063029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-arm multi-stage clinical trials for time-to-event outcomes.
    Dixit V; Mitra P; Simonsen K
    J Biopharm Stat; 2021 Nov; 31(6):838-851. PubMed ID: 34606418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multi-arm multi-stage Bayesian design for phase II drug selection trials - an example in hemato-oncology.
    Jacob L; Uvarova M; Boulet S; Begaj I; Chevret S
    BMC Med Res Methodol; 2016 Jun; 16():67. PubMed ID: 27250349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials.
    Wason JM; Trippa L
    Stat Med; 2014 Jun; 33(13):2206-21. PubMed ID: 24421053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-arm group sequential designs with a simultaneous stopping rule.
    Urach S; Posch M
    Stat Med; 2016 Dec; 35(30):5536-5550. PubMed ID: 27550822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial.
    Choodari-Oskooei B; Thwin SS; Blenkinsop A; Widmer M; Althabe F; Parmar MK
    Clin Trials; 2023 Feb; 20(1):71-80. PubMed ID: 36647713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials.
    Noor NM; Love SB; Isaacs T; Kaplan R; Parmar MKB; Sydes MR
    BMJ Open; 2022 Mar; 12(3):e055615. PubMed ID: 35273052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group sequential multi-arm multi-stage survival trial design with treatment selection.
    Wu J; Li Y
    J Biopharm Stat; 2024 Jul; 34(4):453-468. PubMed ID: 37455424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal design of multi-arm multi-stage trials.
    Wason JM; Jaki T
    Stat Med; 2012 Dec; 31(30):4269-79. PubMed ID: 22826199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designs for adding a treatment arm to an ongoing clinical trial.
    Bennett M; Mander AP
    Trials; 2020 Mar; 21(1):251. PubMed ID: 32143729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.